Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Fierce Health vs LIV by WellNow

Fierce Health
Graded #410

Lower grade

vs+6.299999999999997
LIV by WellNow
Graded #262

Higher grade

The verdict

LIV by WellNow takes it — 62.9/100 to 56.6/100.

LIV by WellNow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. LIV by WellNow is the telehealth weight-management arm of WellNow Urgent Care, offering compounded semaglutide for weight loss.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueLIV by WellNow +18
33
51
Dose & formulationFierce Health +4
77
73
Clinical oversightLIV by WellNow +17
62
79
Labs & monitoringEven
52
52
FulfillmentFierce Health +12
75
63
Contract termsLIV by WellNow +8
47
55
Fierce Health · left barLIV by WellNow · right bar

The numbers

MetricFierce HealthLIV by WellNow
WeighScore56.6/10062.9/100
GradeCC
Scorecard rank#410#262
Semaglutide$297/mo (3-month plan, compounded)$279/mo
Tirzepatide$497/mo (3-month plan, compounded)Not disclosed
Coverage30 states5 states
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Fierce Health

Graded #410 · C

Strengths

  • 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer on every product page
  • Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
  • Microdose tier at $197/mo is one of the lower entry points we've seen

Where it loses points

  • No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
  • Operating LLC name not disclosed anywhere on the site
  • Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
  • Clinical provider network not named
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
LIV by WellNow

Graded #262 · C

Strengths

  • Flat $279/month covers medication, supplies, and unlimited virtual visits
  • Backed by established WellNow Urgent Care brand
  • Board-certified online medical providers
  • Same-day approval and monthly home delivery
  • Transparent all-inclusive pricing with no hidden fees

Where it loses points

  • Compounded semaglutide is not FDA-approved or evaluated
  • Only available in five states (IL, IN, MI, NY, PA)
  • No tirzepatide option offered
  • Insurance not accepted for compounded semaglutide

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard